Cyteir Therapeutics Inc (CYT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2008 | 12-2007 | 09-2007 | 06-2007 | 03-2007 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 49,100 | 207,300 | 158,900 | 106,500 | 51,700 |
| Depreciation Amortization | 39,500 | 145,600 | 107,900 | 72,500 | 36,700 |
| Income taxes - deferred | 2,200 | 27,200 | 14,800 | 15,700 | 9,200 |
| Accounts receivable | -40,800 | -38,800 | -51,300 | -57,600 | -59,900 |
| Accounts payable and accrued liabilities | 29,900 | 2,800 | -5,900 | 1,900 | 23,000 |
| Other Working Capital | -56,200 | -110,300 | -83,900 | -97,800 | -60,600 |
| Other Operating Activity | 14,500 | 36,900 | 54,000 | 49,700 | 24,100 |
| Operating Cash Flow | $38,200 | $270,700 | $194,500 | $90,900 | $24,200 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -26,700 | -114,800 | -65,700 | -39,400 | -14,800 |
| Other Investing Activity | -1,900 | 38,700 | 30,200 | 27,100 | 27,100 |
| Investing Cash Flow | $-28,600 | $-76,100 | $-35,500 | $-12,300 | $12,300 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | -900 | -1,200 | 4,900 | -200 | 300 |
| Debt Issued | 51,100 | 222,000 | 222,000 | 194,100 | 101,600 |
| Debt Repayment | -100,100 | -319,800 | -319,600 | -254,900 | -145,100 |
| Common Stock Issued | 4,100 | 39,300 | 31,800 | 19,000 | 13,700 |
| Common Stock Repurchased | -5,400 | -77,300 | -49,600 | -25,100 | -9,700 |
| Dividend Paid | -6,000 | -19,600 | -14,400 | -9,600 | -4,800 |
| Other Financing Activity | 1,100 | 11,700 | 8,600 | 3,700 | 2,200 |
| Financing Cash Flow | $-56,100 | $-144,900 | $-116,300 | $-73,000 | $-41,800 |
| Exchange Rate Effect | 2,600 | 3,500 | 2,400 | 1,600 | 700 |
| Beginning Cash Position | 76,800 | 23,600 | 23,600 | 23,600 | 23,600 |
| End Cash Position | 32,900 | 76,800 | 68,700 | 30,800 | 19,000 |
| Net Cash Flow | $-43,900 | $53,200 | $45,100 | $7,200 | $-4,600 |
| Free Cash Flow | |||||
| Operating Cash Flow | 38,200 | 270,700 | 194,500 | 90,900 | 24,200 |
| Capital Expenditure | -26,700 | -114,800 | -65,700 | -39,400 | -14,800 |
| Free Cash Flow | 11,500 | 155,900 | 128,800 | 51,500 | 9,400 |